5.0 mL urine in a sterile container, no preservative.
Specimen Required
2.0 mL urine
Specimen Min Vol
1.0 mL urine
Specimen Preparation
None
Storage/Transport Temperature
Refer to Specimen stability criteria as shown below
Ambient
7 days
Refrigerated
1 month
Frozen
1 year
Unacceptable Conditions
Specimens that exceed stated stability, unlabeled/mislabeled/mismatched specimens, specimens submitted in leaking containers
Special Instructions
None
CPT Codes
80354
Synonyms
Fentanil
Sublimaze
Actiq
Durogesic
Duragesic
Fentora
Matrifen
Haldid
Onsolis
Instanyl
Abstral
Lazanda
Methodology
Liquid Chromatography-Tandem Mass Spectrometry (LCMS/MS)
Performing Location
Chemistry (Toxicology)
Reported STAT
Not available
Reported Routine
4 days
Additional Information
Cutoff Concentration: 0.5 ng/mL
This test was developed and its performance characteristics determined by University of California Irvine Medical Center, Department of Pathology and Laboratory Medicine. It has not been approved by the FDA, however, approval is not required for clinical use.
Test set up frequency
Three times a week.
Reference Interval
Negative
Additional Information
Cutoff Concentration: 0.5 ng/mL
This test was developed and its performance characteristics determined by University of California Irvine Medical Center, Department of Pathology and Laboratory Medicine. It has not been approved by the FDA, however, approval is not required for clinical use.
Collection
Collect
5.0 mL urine in a sterile container, no preservative.
Specimen Required
2.0 mL urine
Specimen Min Vol
1.0 mL urine
Specimen Preparation
None
Storage/Transport Temperature
Refer to Specimen stability criteria as shown below
Ambient
7 days
Refrigerated
1 month
Frozen
1 year
Unacceptable Conditions
Specimens that exceed stated stability, unlabeled/mislabeled/mismatched specimens, specimens submitted in leaking containers
Special Instructions
None
Test Info
CPT Codes
80354
Synonyms
Fentanil
Sublimaze
Actiq
Durogesic
Duragesic
Fentora
Matrifen
Haldid
Onsolis
Instanyl
Abstral
Lazanda
Methodology
Liquid Chromatography-Tandem Mass Spectrometry (LCMS/MS)
Performing Location
Chemistry (Toxicology)
Reported STAT
Not available
Reported Routine
4 days
Additional Information
Cutoff Concentration: 0.5 ng/mL
This test was developed and its performance characteristics determined by University of California Irvine Medical Center, Department of Pathology and Laboratory Medicine. It has not been approved by the FDA, however, approval is not required for clinical use.
Test set up frequency
Three times a week.
Result Interpretation
Reference Interval
Negative
Additional Information
Cutoff Concentration: 0.5 ng/mL
This test was developed and its performance characteristics determined by University of California Irvine Medical Center, Department of Pathology and Laboratory Medicine. It has not been approved by the FDA, however, approval is not required for clinical use.
